Verkkokauppa.com Oyj
Verkkokauppa.com Oyj: Acquisition of own shares on 6 November 2025
Verkkokauppa.com Oyj: Acquisition of own shares on 6 November 2025
Verkkokauppa.com Oyj, Stock Exchange Release, 6 November 2025 at 07:00 p.m. EET
Verkkokauppa.com Oyj: Acquisition of own shares on 6 November 2025
| Date | 6 November 2025 | |
| Exchange transaction | Buy | |
| Share trading code | VERK | |
| Amount, shares | 15,354 | |
| Average price/share (EUR) | 3.9441 | |
| Total cost (EUR) | 60,557.71 |
After the acquisitions Verkkokauppa.com Oyj holds a total of 167,905 treasury shares.
On behalf of Verkkokauppa.com Oyj
Danske Bank A/S, Finland Branch
Antti Väliaho Jonathan Nyberg
For more information, please contact:
Jesper Blomster, CFO
Verkkokauppa.com Oyj
jesper.blomster@verkkokauppa.com
Verkkokauppa.com is an e-commerce pioneer that stands passionately on the customer’s side. Verkkokauppa.com accelerates the transition of commerce to online with Finland’s fastest deliveries and ultimate convenience. The company leads the way by offering one-hour deliveries to more than 1.7 million customers, a winning assortment and probably always cheaper prices. Every day, the company strives to find more streamlined ways to surpass its customers' expectations and to create a new norm for buying and owning.
Verkkokauppa.com was founded in 1992 and has been online since day one. The company’s revenue in 2024 was EUR 468 million and it employs around 600 people. Verkkokauppa.com is listed on the Nasdaq Helsinki stock exchange.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S6.11.2025 19:00:56 CET | Press release
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
BONDUELLE6.11.2025 18:00:00 CET | Press release
BONDUELLE - Quarter 1 FY 2025-2026 Sales: The Bonduelle Group confirms its resilience in a demanding environment
Vivoryon Therapeutics N.V.6.11.2025 17:31:00 CET | Press release
Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025
Aspo Plc6.11.2025 17:30:00 CET | Press release
Aspo Plc: Share repurchase 6.11.2025
Chemometec A/S6.11.2025 17:11:48 CET | Pressemeddelelse
Vækst i omsætning og driftsresultat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom